It does not change my statement. FF may do all that we would like it to do but at the present time it has to remain under the heading of investigation/trials and research and whilst it remains that way PXS cannot make any claims and therefore the SP is likely to remain suppressed. You also have to take account that whilst medical advocacy is required natural products are rarely given medical advocacy. Drug companies like it that way for obvious reasons.££££ And so does the medical fraternity.
as far as Directors pay is; its what bit is and same in many companies.If he could give it back it would not do anything for share price. If you want directors renumeration, be a director of something. Not sure what known proven connection to Covid there is, enlighten me? Disease and medical illness requires drug use and approval. FF is not a drug. Updates only come when updates have something to say and can be good or bad by the way. at days end we are in the hands of our big brother company. We all know FF is good and useful but medical sides to any product form part of the drug cartel. They do not want tomatoes taking their drug profits away, not yet anyway.
I did not pick up on anything specific relating to body language, I am sure he is possibly as frustrated as us on progress being slower than what one might suspect. Been here myself, a great idea does not take off as quick as one would like, we forget that end users have their own paths to follow with stringent safety and working policies which need to be followed rigorously . Testing can take an age sometimes and profit from investment needs to be proven etc etc. I know things are slow and we would all like it to be better and we cannot understand why this is not the best thing since sliced bread; but, hey ho. Once we can prove and have the right customer on board; then it will flourish. Just have to keep believing Graphene is all its said to be and costs are manageable. I am sure the cost of graphene is mind boggling and testing timelines will be also.
markparker:_ I understand the sell note as the SP had probably been overpriced for sometime and was probably being held up on the promise of the future of Graphene. The funding issue may not be an issue at all if VRS take up the 15% plus offer that comes via China. I am also confident that they are or have been producing finished article in terms of flake graphene ready to use in applications. That is only guess work on my part though. I would imagine a future fund raise would have some support based around potential or agreed order book for graphene, hexotene, polygrene, nanene etc. Yet again I am hopeful. Having met the management in the past I am confident in their credentials as people but cannot judge them on their business skills all be it based on what we all know thus far. The plan sounds firmly and sensibly based.
Maybe I have not thought this through,but; I imagine these for-said arches will only appear on newly laid tracks to begin with anyway. I cannot see the time and labour and waste of gantries being an option in removing existing gantries and having them redundant?
As far as the arch is concerned, I would agree it has done its job thus far. Initial phase complete, move on to proper trials in a fully working environment. Just an added thought. VRS have permissions to produce up to 10t p.a. That is a lot of graphene when stored. Not to say it would all be produced in its complete bulk, but still a lot. Nice to see some pull back on the SP, hope it continues over the next few days and settles while we wait on next news update. Wont be long now?
Hi Robin, A bit confused this past week trying to understand such a large drop. A drop in itself not surprising as many are perhaps tired of waiting for the promise in the material to show its true colours in proving itself. News is becoming ever more important. Maybe the drop was a snowball that just grew bigger and bigger, seen it before of course in other shares. No doubt the SP was overpriced presently. I did not sell any but now sit on a loss I can do without. NR being silent on Twitter is puzzling, maybe trying to shut up TW by not engaging. More alarming might be that Graphene manufacturing has hit a snag at the factory, lets hope not, although the company would not want to say so. If NR can justify reappearing on Twitter that might steady a few doubters and most certainly would be progress with a potential customer firming up an order or two. Conovirus may have played a part in the fall with some shareholders selling out to get in elsewhere? Def: need VRS to firm up a business deal and prove that users out there are prepared to purchase and include the product(s) into their businesses.
I agree, a great fit I would think. Last line of statement very interesting.
By-Health, a national supplement brand in China, officially released an energy drink brand “F6 Supershot”, and held a press conference in Guangzhou. According to the company’s executive,the new product would cover 30,000 retail places, which would help make F6 a leading brand in the local energy drink market. The company also said that it would soon roll out more functional drinks for other health purposes.
Some rather bold opinions of other people in your last post father... Certainly not out to win freinds by looks of it? Anyway, back to Graphene. Possibly the biggest threat to VRS at present are those companies making claims on products when those companies do not have ISO approval. Graphene failure to meet expectations, could hold back VRS for a while?
Not sure that is a fair adjective of Chris's nature, (parsimonious) so not sure where it comes from. VRS are a small team that work closely together and decision make together from my contact with them.
Surprised no one has mentioned Spirit Aerosystems today even though they are mentioned in todays RNS. Has it got lost in the fog? Big company with very close ties to Boeing. Pity Boeing are where they are at present of course, but, connect to Spirit potentially massive.